Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Nanoparticle-based systems for concurrent delivery of multiple drugs can improve outcomes of cancer treatments, but face challenges because of differential solubility and fairly low threshold for incorporation of many drugs. Here we demonstrate that this approach can be used to greatly improve the treatment outcomes of etoposide (ETO) and platinum drug combination ("EP/PE") therapy that is the backbone for treatment of prevalent and deadly small cell lung cancer (SCLC). A polymeric micelle system based on amphiphilic block copolymer poly(2-oxazoline)s (POx) poly(2-methyl-2-oxazoline- block-2-butyl-2-oxazoline- block-2-methyl-2-oxazoline) (P(MeOx- b-BuOx- b-MeOx) is used along with an alkylated cisplatin prodrug to enable co-formulation of EP/PE in a single high-capacity vehicle. A broad range of drug mixing ratios and exceptionally high two-drug loading of over 50% wt. drug in dispersed phase is demonstrated. The highly loaded POx micelles have worm-like morphology, unprecedented for drug loaded polymeric micelles reported so far, which usually form spheres upon drug loading. The drugs co-loading in the micelles result in a slowed-down release, improved pharmacokinetics, and increased tumor distribution of both drugs. A superior antitumor activity of co-loaded EP/PE drug micelles compared to single drug micelles or their combination as well as free drug combination was demonstrated using several animal models of SCLC and non-small cell lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Triblock A-B-A copolymers of POx consisting of hydrophobic PBuOx block with two flanking hydrophilic PMeOx blocks, PMeOx-b-PBuOx-b-PMeOx, have shown unprecedentedly high loading for many poorly soluble drugs [22, 45, 113, 114].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the effective and safe delivery of drug combinations, the combination drugs should be well-solubilized in the polymeric micelle so that the amount of the excipient and injection volume can be minimized for parenteral injection [114, 188, 240].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A high LC also increases the amount of drug per micelle, which can increase the amount of drug internalized into cells [114].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They reported that the overall AUC of the drugs in the tumor from worm-like micelles were higher than from spherical micelles.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This study suggested that the worm-shaped POx micelles co-loaded with two drugs (etoposide and hydrophobic cisplatin analog) have increased accumulation of the drugs into tumor compared to spherical micelles loaded with just one drug.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Arnida, Janát-Amsbury, M. M., Ray, A., Peterson, C. M., & Ghandehari, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.010 · Cited by 547
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0011 · Cited by 436
Molecular mechanisms of etoposide.
Montecucco, A., Zanetta, F., & Biamonti, G. (2015) · EXCLI journal · doi:10.17179/excli2015-561 · Cited by 291
Research works printed but not linked: 3
- Chan B. A., 2013, J. Thorac. Dis., 5, S565
- Johnson S. W., 1997, Cancer Res., 57, 850
- Montecucco A., 2015, EXCLI Journal, 14, 95
Cited by
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“A high LC also increases the amount of drug per micelle, which can increase the amount of drug internalized into cells [114].”
BackgroundInfluentialSelf-citationCurrent advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Polymeric micelles in cancer therapy: State of the art
Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 546
Poly(2-oxazoline)s based biomaterials: a comprehensive and critical update
Lorson, T., Lübtow, M. M., Wegener, E., Haider, M. S., Borova, S., Nahm, D., Jordan, R., Sokolski-Papkov, M., Kabanov, A. V., & Luxenhofer, R. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.022 · Cited by 391
Self-citationWan, X., Beaudoin, J. J., Vinod, N., Min, Y., Makita, N., Bludau, H., Jordan, R., Wang, A., Sokolsky, M., & Kabanov, A. V. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.032 · Cited by 201
Self-citationKesharwani, P., Choudhury, H., Meher, J. G., Pandey, M., & Gorain, B. (2019) · Progress in Materials Science · doi:10.1016/j.pmatsci.2019.03.003 · Cited by 170
The in vivo fate of polymeric micelles
Cai, Y., Qi, J., Lu, Y., He, H., & Wu, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114463 · Cited by 154
Mall, J., Naseem, N., Haider, M. F., Rahman, M. A., Khan, S., & Siddiqui, S. N. (2024) · Intelligent Pharmacy · doi:10.1016/j.ipha.2024.09.005 · Cited by 156
Wen, X., Zhang, R., Hu, Y., Wu, L., Bai, H., Song, D., Wang, Y., An, R., Weng, J., Zhang, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36469-1 · Cited by 154
Integrating Nanotechnology into Cancer Care
Grodzinski, P. A., Kircher, M. F., Goldberg, M. S., & Gabizón, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b04266 · Cited by 147
Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Zhang, Y., Cui, H., Zhang, R., Zhang, H., & Huang, W. (2021) · Advanced Science · doi:10.1002/advs.202101454 · Cited by 135
Drug Delivery Systems Based on Poly(2‐Oxazoline)s and Poly(2‐Oxazine)s
Sedláček, O., & Hoogenboom, R. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900168 · Cited by 135
Zhao, W., Cong, Y., Li, H., Li, S., Shen, Y., Qi, Q., Zhang, Y., Li, Y., & Ya-jie Tang, A. (2020) · Natural Product Reports · doi:10.1039/d0np00041h · Cited by 120
Different Strategies for Organic Nanoparticle Preparation in Biomedicine
Fang, F., Li, M., Zhang, J., & Lee, C. (2020) · ACS Materials Letters · doi:10.1021/acsmaterialslett.0c00078 · Cited by 123
Zahoranová, A., & Luxenhofer, R. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001382 · Cited by 119
Haider, M. S., Lübtow, M. M., Endres, S., Forster, S., Flegler, V. J., Böttcher, B., Aseyev, V., Pöppler, A.-C., & Luxenhofer, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22495 · Cited by 100
New Advances in Biomedical Application of Polymeric Micelles
Figueiras, A., Domingues, C., Jarak, I., Santos, A. I., Parra, A., Pais, A. A. C. C., Alvarez‐Lorenzo, C., Concheiro, Á., Kabanov, A. V., Cabral, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081700 · Cited by 111
“Using a rational computer‐ aided approach, POx micelles that were loaded with chemosensitizers, anticancer agents, and immunomodulating small molecules were designed to improve the treatment of non‐ small cell lung cancer (NSCLC) [58] (Figure 3), triple‐negative, and other condition can‐ cers.”
BackgroundMethodInfluentialSelf-citationSynergistic Solvent Extraction Is Driven by Entropy
Špadina, M., Bohinc, K., Zemb, T. N., & Dufrêche, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b07605 · Cited by 96
Lübtow, M. M., Nelke, L. C., Seifert, J., Kühnemundt, J., Sahay, G., Dandekar, G., Nietzer, S., & Luxenhofer, R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.014 · Cited by 89
Nanotechnology: Breaking the Current Treatment Limits of Lung Cancer
Li, S., Xu, S., Liang, X., Xue, Y., Mei, J., Ma, Y., Liu, Y., & Liu, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100078 · Cited by 86
Song, C., Li, Y., Li, T., Yang, Y., Huang, Z., de la Fuente, J. M., Ni, J., & Cui, D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201906309 · Cited by 85
Zhang, M., Hagan, C. T., Foley, H., Tian, X., Yang, F., Au, K. M., Mi, Y., Medik, Y. B., Roche, K. C., Wagner, K., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.001 · Cited by 77
Self-citationYang, T., Yang, L., Cao, M., Ma, X., Cao, A., Sun, Y., Yang, J., Li, L., & Liu, Y. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.082 · Cited by 75
Lim, C., Ramsey, J. D., Hwang, D., Teixeira, S. C. M., Poon, C., Strauss, J. D., Rosen, E. P., Sokolsky‐Papkov, M., & Kabanov, A. V. (2021) · Small · doi:10.1002/smll.202103552 · Cited by 76
Self-citationLagarrigue, P., Moncalvo, F., & Cellesi, F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010032 · Cited by 78
Xia, Y., Chen, Y., Hua, L., Zhao, M., Xu, T., Wang, C., Li, Y., & Zhu, B. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s174909 · Cited by 69
Ganda, S., Wong, C. K., & Stenzel, M. H. (2021) · Macromolecules · doi:10.1021/acs.macromol.1c00643 · Cited by 66
PEGylation technology: addressing concerns, moving forward
Simberg, D., Barenholz, Y., Roffler, S. R., Landfester, K., Kabanov, A. V., & Moghimi, S. M. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2494775 · Cited by 67
“…emerged as a novel polymeric micelle platform for drug delivery, uniquely capable of carrying high loads of water-insoluble drugs with improved safety (He et al. 2016; Lübtow et al. 2017; Wan et al. 2018; Alves et al. 2019; Hwang et al. 2020, 2021; Zahoranová and Luxenhofer 2021; Lim et al. 2023).”
Self-citationVinod, N., Hwang, D., Azam, S. H., Van Swearingen, A. E. D., Wayne, E., Fussell, S. C., Sokolsky-Papkov, M., Pecot, C. V., & Kabanov, A. V. (2020) · Science Advances · doi:10.1126/sciadv.aba5542 · Cited by 63
“The lack of any anticancer activity of POx alone has been previously demonstrated in this model (35).”
Self-citationTopoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems
Dehshahri, A., Ashrafizadeh, M., Afshar, E. G., Pardakhty, A., Mandegary, A., Mohammadinejad, R., & Sethi, G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104551 · Cited by 65
The Trojan Horse Goes Wild: The Effect of Drug Loading on the Behavior of Nanoparticles
Stenzel, M. H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010934 · Cited by 69
Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
Alves, V. M., Hwang, D., Muratov, E., Sokolsky-Papkov, M., Varlamova, E., Vinod, N., Lim, C., Andrade, C. H., Tropsha, A., & Kabanov, A. (2019) · Science Advances · doi:10.1126/sciadv.aav9784 · Cited by 56
“The particle size andmorphology along with the micelle stability and drug release characteristics are important parameters for the pharmacological performance of these drug delivery systems (31).”
BackgroundSelf-citationJana, S., & Hoogenboom, R. (2022) · Polymer International · doi:10.1002/pi.6426 · Cited by 57
Lim, C., Hwang, D., Yazdimamaghani, M., Atkins, H., Hyun, H., Shin, Y., Ramsey, J. D., Rädler, P. D., Mott, K. R., Perou, C. M., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2023.101884 · Cited by 56
Self-citationHahn, L., Lübtow, M. M., Lorson, T., Schmitt, F., Appelt‐Menzel, A., Schobert, R., & Luxenhofer, R. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00708 · Cited by 60
Cao, C., Chen, F., Garvey, C. J., & Stenzel, M. H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09054 · Cited by 60
Shi, M., Zhang, J., Huang, Z., Chen, Y., Pan, S., Hu, H., Qiao, M., Chen, D., & Zhao, X. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02764e · Cited by 53
Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer
Uz, M., Kalaga, M., Pothuraju, R., Ju, J., Junker, W. M., Batra, S. K., Mallapragada, S. K., & Rachagani, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.031 · Cited by 51
Zhao, J., Lu, H., Yao, Y., Ganda, S., & Stenzel, M. H. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00706c · Cited by 51
Dendrimer-Based Nanocarriers in Lung Cancer Therapy
Gorain, B., Choudhury, H., Pandey, M., Nair, A. B., Amin, M. C. I. M., Molugulu, N., Deb, P. K., Tripathi, P. K., Khurana, S., Shukla, R., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815720-6.00007-1 · Cited by 62
Ganguly, R., Kumar, S., Tripathi, A., Basu, M., Verma, G., Sarma, H. D., Chaudhari, D., Aswal, V. K., & Melo, J. S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113231 · Cited by 49
Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
Chen, N., Qi, Y.-L., Ma, X., Xiao, X., Liu, Q., Xia, T., Xiang, J., Zeng, J., & Tang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906301 · Cited by 49
“In lung cancers, approximately 80–85% are non–small cell lung cancer (NSCLC), and 10–15% are small cell lung cancer (Wan et al., 2018).”
BackgroundWang, W., Hao, Y., Liu, Y., Li, R., Huang, D., & Pan, Y. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1654 · Cited by 51
Nanomaterials innovation as an enabler for effective cancer interventions
Russell, L. M., Liu, C. H., & Grodzinski, P. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119926 · Cited by 46
Lübtow, M. M., Mrlík, M., Hahn, L., Altmann, A., Beudert, M., Lühmann, T. C., & Luxenhofer, R. (2019) · Journal of Functional Biomaterials · doi:10.3390/jfb10030036 · Cited by 49
Ibarra-Sánchez, L. Á., Gámez-Méndez, A. M., Martínez-Ruiz, M., Nájera-Martínez, E. F., Morales-Flores, B., Melchor-Martínez, E. M., Sosa‐Hernández, J. E., Parra‐Saldívar, R., & Iqbal, H. M. N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103219 · Cited by 49
Liu, J., Chi, D., Pan, S., Zhao, L., Wang, X., Wang, D., & Wang, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.072 · Cited by 44
Advances of podophyllotoxin and its derivatives: Patterns and mechanisms
Shi, R.-J., Fan, H., Yu, X., Tang, Y., Jiang, J., & Liang, X. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115039 · Cited by 43
Zhu, Y., Yu, F., Tan, Y., Hong, Y. K., Meng, T., Liu, Y., Dai, S., Qiu, G., Yuan, H., & Hu, F. (2019) · Theranostics · doi:10.7150/thno.36334 · Cited by 43
“4, 10% fetal bovine serum) at 37°C [28, 29].”
Applications of Aptamer-Bound Nanomaterials in Cancer Therapy
Zhu, L., Zhao, J., Guo, Z., Liu, Y., Chen, H., Zhu, C., & He, N. (2021) · Biosensors · doi:10.3390/bios11090344 · Cited by 42
Supramolecular nanomedicines through rational design of self-assembling prodrugs
Wang, H., Monroe, M. K., Leslie, F., Flexner, C. W., & Cui, H. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.003 · Cited by 43
Lim, C., Dismuke, T., Malawsky, D. S., Ramsey, J. D., Hwang, D., Godfrey, V., Kabanov, A. V., Gershon, T. R., & Sokolsky‐Papkov, M. (2022) · Science Advances · doi:10.1126/sciadv.abl5838 · Cited by 43
“S6D) ( 30 , 32 ).”
Self-citationHwang, D., Ramsey, J. D., Makita, N., Sachse, C., Jordan, R., Sokolsky-Papkov, M., & Kabanov, A. V. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.037 · Cited by 40
“These formulations can contain up to 50–100 g/L of poorly soluble drugs [23,25,26].”
BackgroundSelf-citationPeng, J., Xiao, Y., Yang, Q., Liu, Q., Chen, Y., Shi, K., Hao, Y., Han, R., & Qian, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.013 · Cited by 40
Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery
Shao, W., Yang, Y., Shen, W., Ren, L., WenwenWang, & Zhu, P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132671 · Cited by 42
A nano-complex system to overcome antagonistic photo-chemo combination cancer therapy
Lim, C., Moon, J., Sim, T., Won, W. R., Lee, E. S., Youn, Y. S., & Oh, K. T. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.043 · Cited by 37
Lübtow, M. M., Marciniak, H., Schmiedel, A., Roos, M., Lambert, C., & Luxenhofer, R. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201902619 · Cited by 35
Yazdimamaghani, M., Kolupaev, O., Lim, C., Hwang, D., Laurie, S. J., Perou, C. M., Kabanov, A. V., & Serody, J. S. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122750 · Cited by 38
Self-citationWang, Y., Zhang, Z., Zhao, X., Xu, L., Zheng, Y., Li, H., Guo, D., Shi, L., & Liu, Y. (2022) · Theranostics · doi:10.7150/thno.72559 · Cited by 35
“To date, several nano-drug delivery systems (nanoDDS), such as polymer micelles [14-16] and liposomes [17], have been investigated for use in the co-delivery of multiple drugs [18-25].”
BackgroundSochor, B., Düdückcü, Ö., Lübtow, M. M., Schummer, B., Jaksch, S., & Luxenhofer, R. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b03460 · Cited by 34
Luo, H., Jiang, K., Liang, X., Liu, H., & Li, Y. (2019) · Soft Matter · doi:10.1039/c9sm01644a · Cited by 33
Garcia-Hernandez, J. D., Street, S. T. G., Kang, Y., Zhang, Y., & Manners, I. (2021) · Macromolecules · doi:10.1021/acs.macromol.1c00672 · Cited by 33
Sun, H., Chen, S., Li, X., Leng, Y., Zhou, X., & Du, J. (2022) · Nature Communications · doi:10.1038/s41467-022-29863-8 · Cited by 32
Formulation and In Vitro Evaluation of Upconversion Nanoparticle-Loaded Liposomes for Brain Cancer
Narendra, N., Mehata, A. K., Viswanadh, M. K., Sonkar, R., Pawde, D. M., Priya, V., Singh, M., Koch, B., & Muthu, M. S. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0070 · Cited by 31
Kobayashi, E., Hwang, D., Bheda-Malge, A., Whitehurst, C. B., Kabanov, A. V., Kondo, S., Aga, M., Yoshizaki, T., Pagano, J. S., Sokolsky‐Papkov, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153733 · Cited by 31
Self-citationKhursheed, R., Paudel, K. R., Gulati, M., Vishwas, S., Jha, N. K., Hansbro, P. M., Oliver, B. G. G., Dua, K., & Singh, S. K. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0451 · Cited by 29
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
Haider, M. S., Ahmad, T., Gröll, J., Scherf‐Clavel, O., Kroiß, M., & Luxenhofer, R. (2021) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-021-00700-5 · Cited by 35
“injection in mice), which has demonstrated superior antitumor efficacy on various small cell and non-small cell lung cancer models compared to single formulations [120].”
BackgroundHe, W., Xiao, W., Zhang, X., Sun, Y., Chen, Y.-T., Chen, Q., Fang, X., Du, S., & Sha, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s229576 · Cited by 28
Shuai, Q., Zhao, G., Lian, X., Wan, J., Cen, B., Zhang, W., Liu, J., Su, W., & Wang, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118879 · Cited by 27
Tao, J., Tan, Z., Diao, L., Ji, Z., Zhu, J., Chen, W., & Hu, Y. (2018) · RSC Advances · doi:10.1039/c8ra02833h · Cited by 27
Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects
Farooq, M. A., Aquib, M., Khan, D. H., Ghayas, S., Ahsan, A., Ijaz, M., Banerjee, P., Khan, M. A., Ahmad, M. M., & Wang, B. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00897-7 · Cited by 26
“Another researcher combined etoposide and cisplatin in polymeric micelles for improvement in pharmacokinetics and controlled release of encapsulated therapeutic agents (Wan et al. 2018).”
BackgroundLübtow, M. M., Lorson, T., Finger, T., Gröber‐Becker, F., & Luxenhofer, R. (2019) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201900341 · Cited by 26
Poly(2-oxazoline)s: synthesis and biomedical applications
Yang, L., Wang, F., Ren, P., Zhang, T., & Zhang, Q. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00116-x · Cited by 27
Assessing the pharmacokinetics and toxicology of polymeric micelle conjugated therapeutics
Thotakura, N., Parashar, P., & Raza, K. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1862085 · Cited by 26
Landry, M. R., DuRoss, A. N., Neufeld, M. J., Hahn, L., Sahay, G., Luxenhofer, R., & Sun, C. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100082 · Cited by 28
“9 a greater chance that both drugs reach the same cell rather than separate cells, which could account for increased synergistic efficacy [41,55-57].”
BackgroundWormlike Nanovector with Enhanced Drug Loading Using Blends of Biodegradable Block Copolymers
Ridolfo, R., Arends, J. J., van Hest, J. C. M., & Williams, D. S. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00169 · Cited by 25
Bai, J., Tian, Y., Liu, F., Li, X., Shao, Y., Lu, X., Wang, J., Zhu, G., Xue, B., Liu, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b01827 · Cited by 23
Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications
Mougin, J., Bourgaux, C., & Couvreur, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.018 · Cited by 23
Haider, M. S., Schreiner, J., Kendl, S., Kroiß, M., & Luxenhofer, R. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900178 · Cited by 23
Zhang, X., Chen, J., Cheng, C., Li, P., Cai, F., Xu, H., Lu, Y., Cao, N., Liu, J., Wang, J., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920947976 · Cited by 27
Dong, S., Ma, S., Liu, Z., Ma, L., Zhang, Y., Tang, Z., Deng, M., & Song, W. (2021) · Chinese Journal of Polymer Science · doi:10.1007/s10118-021-2547-6 · Cited by 21
Polymeric micelle-based drug delivery systems for tuberculosis treatment
Gorain, B., Choudhury, H., Sisinthy, S. P., & Kesharwani, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00011-4 · Cited by 23
Zhang, N., Liu, W., Dong, Z., Yin, Y., Luo, J., Lu, T., Tang, W., Wang, Y., & Han, Y. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00385 · Cited by 20
Pavan, S. R., & Prabhu, A. (2022) · Journal of Materials Science · doi:10.1007/s10853-022-07649-z · Cited by 21
“The C6CP/ ETO PM group had the lowest IC50 value among the three drug ratios in in vitro investigations, and in in vivo tests, C6CP/ETO PM exhibited a drastic reduction in tumor in both the models [53].”
BackgroundLi, X., Hu, S., Lin, Z. R., Yi, J., Liu, X., Tang, X., Wu, Q., & Zhang, G. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0440 · Cited by 19
Kumar, K., & Chawla, R. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102677 · Cited by 19
GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma
Bai, R., Zhang, J., He, F., Li, Y., Dai, P., Huang, Z., Han, L., Wang, Z., Gong, Y. Q., & Xie, C. (2022) · Communications Biology · doi:10.1038/s42003-022-03506-6 · Cited by 19
Mougin, J., Yesylevskyy, S. O., Bourgaux, C., Chapron, D., Michel, J., Dosio, F., Stella, B., Ramseyer, C., & Couvreur, P. (2019) · ACS Nano · doi:10.1021/acsnano.9b05303 · Cited by 17
Si, P., Shi, J., Zhang, P., Wang, C., Chen, H., Mi, X., Chu, W., Zhai, B., & Li, W. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.019 · Cited by 17
Xie, W., Jiang, C., Yu, X., Shi, X., Wang, S., Sun, Y., Yin, M., & Wu, D. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c00879 · Cited by 17
Lim, C., Kang, J. K., Won, W. R., Park, J. Y., Han, S. M., Le, T. N., Kim, J. C., Her, J., Shin, Y., & Oh, K. T. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060293 · Cited by 17
“It is well known that the cellular uptake efficiency of multiple drug i a single nanoparticle system is better than that of a mixture f s veral singl drugs in different n nop rticle systems [25,28]; us pointing to the importance of the physicochemical characteristics of drug carri rs n combin tion therapy.”
BackgroundWong, S., Cao, C., Lessio, M., & Stenzel, M. H. (2022) · Nanoscale · doi:10.1039/d2nr01795d · Cited by 16
Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy
Zheng, K., Liu, H., Liu, X., Wang, Y., Li, L., Li, S., Xue, J., & Huang, M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s227144 · Cited by 16
Wang, Y., Chen, L., Zhang, Z., Liu, W., & Li, L. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01105-2 · Cited by 17
“0 software, and the CI values was calculated using CompuSyn software based on the Chou and Talalay method [21, 22].”
MethodPlatinum Drug‐Incorporating Polymeric Nanosystems for Precise Cancer Therapy
Liu, W., Li, X., Wang, T., Xiong, F., Sun, C., Yao, X., & Huang, W. (2023) · Small · doi:10.1002/smll.202208241 · Cited by 17
Wang, H., Deng, H. X., Gao, M., Zhang, Y., Liu, R., Hou, W., Xu, H., & Zhang, W. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.3c00747 · Cited by 15
Xie, P., & Liu, P. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118760 · Cited by 18
Potential Use of Multifunctional Nanoparticles for the Treatment of Cardiovascular Diseases
Kleinstreuer, C. (2018) · Journal of Cardiology and Cardiovascular Sciences · doi:10.29245/2578-3025/2018/3.1134 · Cited by 15
Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers
Deng, Z., Siraj, A. A., Lowry, I., Ruan, E., Patel, R., Gao, W., Kalin, T. V., & Kalinichenko, V. V. (2025) · Bioengineering · doi:10.3390/bioengineering12090968 · Cited by 17
“Recently, CP has been conjugated with fatty acids to form a hydrophobic CP prodrug, which was later encapsulated with hydrophobic agents such as etoposide and PTX into PLGA-PEG polymeric NPs [125–127].”
Luo, H., Tang, Q., Zhong, J., Lei, Z., Zhou, J., & Tong, Z. (2019) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201800508 · Cited by 14
Metadata
- Authors
- Wan, X., Min, Y., Bludau, H., Keith, A., Sheiko, S. S., Jordan, R., Wang, A. Z., Sokolsky-Papkov, M., & Kabanov, A. V.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Technische Universität Dresden (DE)
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
- Corresponding author
- Kabanov, Alexander V.
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-03-13
- Volume
- 12
- Issue
- 3
- Pages
- 2426-2439
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- PMC
- PMC5960350
- OpenAlex
- W2792801574
- Cited by
- 158
- References
- 30
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 11 · 2023: 14 · 2022: 25 · 2021: 25 · 2020: 27 · 2019: 28 · 2018: 12
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (U01 CA116591, U54 CA198999, R21 CA182322)
- China Scholarship Council (2011601254)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Keywords
- poly(2-oxazoline), small cell lung cancer, non-small cell lung cancer, etoposide, cisplatin prodrug, platinum drugs, drug synergy, amphiphilic block copolymers, controlled drug release, tumor distribution, pharmacokinetics, anticancer activity
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cisplatin, Drug Carriers, Drug Synergism, Etoposide, Female, Humans, Lung Neoplasms, Mice, Nude, Micelles, Polymers, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.